壳聚糖氧化海藻酸钠水凝胶作药物载体的细胞毒性和生物相容性研究

合集下载

海藻酸钠水凝胶药物释放

海藻酸钠水凝胶药物释放

海藻酸钠水凝胶及在药物释放中的应用(武汉大学化学院2013级研究生)摘要:海藻酸钠具有良好的生物相容性,pH值敏感性,可在温和的条件快速的形成水凝胶,水凝胶通常是由亲水性或两亲性高分子链组成的三维网状结构,它能显著的溶胀于水但是不溶解于水,由于水和凝胶网络的亲和性,水可能以键合水、束缚水和自由水等形式存在于高分子网络中而失去流动性,因此纳米凝胶能够保持一定的形状。

它们可以作为一种药物载体,而且也可以通过盐键,氢键或者疏水作用自发的结合一些生物活性分子。

海藻酸钠作为药物载体已被广泛研究。

本文主要对海藻酸钠的结构与性能、水凝胶的制备与应用做简要概述。

关键词:海藻酸钠水凝胶释药0 引言高分子凝胶是由三维网络结构的高分子和溶胀介质构成,网络可以吸收介质而溶胀,介质可以是气体或者液体。

以水为溶胀介质的凝胶称为水凝胶[l]。

一般情况下,水凝胶同时具有固体和液体的性质。

比如,水凝胶具有一定的形状,并可以通过一定的方式改变其形状,具有固体的性质。

又比如,在溶胀的水凝胶中,所含有的水分子具有较大的扩散系数,这和液体的性质相类似[2]。

但是水凝胶所含有的水可以有几种存在状态,如束缚水、自由水等[3],这又与一般的液体特性不同。

同时,水凝胶还呈现出体积相转变现象,即水凝胶的体积会随着外界的温度、pH值、离子强度、光、电场强度的变化而变化[4]一般将具有这种相变的水凝胶称为智能水凝胶。

由于这些奇特的性质,水凝胶被广泛地应用于卫生、医药、食品、农业、建筑等领域。

近年来,由于智能水凝胶在药物的控制释放、基因传送、组织工程等领域的应用前景诱人,因此,科学工作者对智能水凝胶的研究十分活跃。

水凝胶根据来源不同可以分为合成类水凝胶和天然类水凝胶。

合成类水凝胶常用的单体有丙烯酸及其衍生物、丙烯酞胺及其衍生物等,合成水凝胶具有较好的稳定性,但其生物降解性和生物相容性较差。

如常用的丙烯酞胺类物质及其衍生物生物相容性较差,且不可降解,还可能会对人体产生毒副作用[5]。

壳聚糖作为药物载体在医学领域中的应用

壳聚糖作为药物载体在医学领域中的应用

壳聚糖作为药物载体在医学领域中的应用摘要:壳聚糖的理化性质、生物活性以及安全性都符合作为药物载体的标准,药物包封于壳聚糖后其释放主要决定壳聚糖的生物降解和溶蚀,控制药物释药的浓度和时间,使药物的释放时间明显延长,对疾病治疗另辟了新的方法和途径。

关键字:壳聚糖药物载体医学应用前言作为新型药物输送和控释载体,可生物降解的聚合物纳米粒子,特别是基于多糖的纳米微球和纳米微囊,因其具有良好的生物相容性、超细粒径、合理的体内分布和高效的药物利用率,近年日益受到广泛关注。

可生物降解聚合物纳米微粒不仅可增强药物的稳定性、提高疗效、降低毒副作用,而且可有效地越过许多生物屏障和组织间隙到达病灶部位,从而更有效地对药物进行靶向输送和控制释放,是包埋多肽、蛋白质、核酸、疫苗一类生物活性大分子药物的理想载体[1]。

壳聚糖是一种生物可降解的高分子聚合物,由于其良好的生物可降解性、对生物黏膜较强的黏附性、无毒性及组织相容性,是一种理想的药物载体。

由壳聚糖制备的纳米微球可以能够提高药物的稳定性、提高了疏水性药物的溶解度、改变给药途径、增加药物的吸收、提高药物的生物利用度、降低药物的不良反应等特点;也可以缓释、控释、靶向释放药物等。

因此,壳聚糖纳米微球作为药物载体有着巨大的应用潜力。

1.1壳聚糖的物理化学及生物学性质随着对其物理化学和生物特性的不断揭示,壳聚糖基纳米微粒现已被认为是一类极具应用前景的药物控释载体,特别适用于具有生物活性大分子药物的包埋和释放。

从技术角度来看,壳聚糖最重要的优势在于它的可溶性和带正电性,这些特点使其在液态介质中可与带负电荷的聚合物、大分子甚至一些聚阴离子相互作用,由此发生的溶胶-凝胶转变过程则可方便地用于载药纳米微粒的制备;从生物药剂角度来看,壳聚糖纳米微粒具有附着在生物体粘膜表面的特性,这使得它尤其适用于粘膜药物的靶向输送。

黄小龙等[2]通过实验证明了壳聚糖纳米粒子能打开小肠上皮细胞间紧密的节点,使大分子药物更易越过上皮组织、增加药物在小肠内的吸收;Luessen等[3]用壳聚糖纳米微粒包埋多肽类药物-布舍若林,发现药物在小鼠体内吸收的生物利用度达5.1%,而未被包埋药物的生物利用度仅为0.1%。

海藻酸钠的研究与应用进展

海藻酸钠的研究与应用进展

海藻酸钠的研究与应用进展作者:彭琪琪来源:《大经贸》 2019年第7期彭琪琪【摘要】海藻酸钠(SA)是从褐藻类的海带或马尾藻中提取的一种天然多糖类物质,是由β-D-甘露糖醛酸和α-L-古洛糖醛酸按(1→4)键连接而成,具有pH敏感性和一定的黏附性,安全环保,成本低廉,广泛应用于医疗、食品包装、环境污染治理等领域[1]。

本文对近十年海藻酸钠的研究与应用进行了探讨。

【关键词】海藻酸钠医药领域食品保鲜污水治理海藻酸钠又称褐藻酸钠,是一种从海藻中提取的天然高分子多糖,无毒,可生物降解,具有良好的生物相容性和pH敏感性。

海藻酸钠作为阴离子型高分子,遇阳离子可形成凝胶层,形成条件温和,适合用于医药领域作为药物缓释载体[2]。

除此之外,海藻酸钠具有良好的保湿性、抗菌性、透气性等特点,可以有效地进行食品保鲜。

海藻酸钠来源广泛、成本低廉,有利于推广工业化应用。

1.医药领域的研究与应用海藻酸钠在医药领域的巨大潜能使其成为当今的研究热点。

在普通的药物治疗中,药物的突释会降低疗效,增加药物的服用频率,加重患者的身体和经济负担。

而药物治疗在医疗领域占有相当大的比重,因此提高药物疗效一直是人们关注的重点。

海藻酸钠形成的水凝胶能够阻滞药物释放,达到缓释效果。

并且,利用海藻酸钠制得的药物载体可彻底降解、容易排泄,适用于体内药物治疗[3]。

海藻酸钠具有良好的生物相容性、无毒、可生物降解等优点,因此可用于制作生物支架,满足医用需求。

毛伟等人[4]利用0.25%的氯化铁溶液增强海藻酸钠水凝胶空心圆管的力学性能,制得较稳定的空心圆管及其类血管网络支架,可有效运输和灌注细胞培养液。

2.食品工业的研究与应用海藻酸钠可有效抑制食品表面微生物的生长,延长食品保鲜期。

对于食品,安全性永远是不容忽视的问题,近年来出现的无机和有机抗菌薄膜安全性问题仍令人担忧。

而海藻酸钠作为天然多糖物质,无毒、生物降解性良好,安全环保,因此被广泛应用于蔬菜、水果、肉类以及海产品等的保鲜中。

氧化海藻酸钠交联壳聚糖载药复合体系的制备及其药物缓释初步研究

氧化海藻酸钠交联壳聚糖载药复合体系的制备及其药物缓释初步研究

氧化海藻酸钠交联壳聚糖载药复合体系的制备及其药物缓释初步研究*张 旭1,2,顾志鹏1,徐源廷1,李 华1,余喜讯1,2(1.四川大学高分子科学与工程学院,四川成都610065;2.四川大学苏州研究院,江苏苏州215123)摘 要: 为获得一种新型的药物释放复合体系,本实验首先通过乳化交联法制备壳聚糖(CS)包载四环素(TC)微球,然后利用氧化海藻酸钠交联聚磷酸钙/壳聚糖(CPP/CS)复合材料,用冷冻干燥法制备了载药微球复合体系。

并用傅立叶红外光谱仪(IR)、扫描电镜(SEM)及药物的体外释放等方法对该载药微球复合体系进行分析和表征。

结果显示,经过氧化海藻酸钠交联的CPP/CS复合材料中无机相均匀分散在连续有机相基体中,制备的CPP/CS空白复合体系与载药微球复合体系具有较为理想的孔隙结构和贯通性。

其中的微球均呈球状,粒径分布在5~50μm之间,微球表面光滑且比较致密,载药后有利于减缓药物的突释效应。

载药微球复合后,微球在复合体系中分布均匀,而且与CPP/CS材料之间亲合性较好,其药物的缓释效果得到明显的提高。

实验将为制备出具有能满足药物缓释材料的需要,又能进行骨缺损的修复的双功能的复合药物载体进行了初步探索。

关键词: 氧化海藻酸钠;壳聚糖;聚磷酸钙;复合体系;药物缓释中图分类号: R318.08文献标识码:A文章编号:1001-9731(2011)05-0894-031 引 言目前,很多疾病如慢性骨髓炎等的治疗[1]需在病灶部位保持较为稳定的抗生素药物浓度,同时还要修复因疾病造成的骨缺损。

口服和药物注射等治疗方法难以使药物到达病灶,效果较差,故对药物缓释体系的研究方兴未艾[2]。

许多研究表明,采用微球载体技术[3],可有效地保持药物活性,并实现药物控释和靶向释药的目的,从而显著地提高疗效,并能降低药物毒副作用。

壳聚糖(CS)因其生物相容性好[4],被广泛用于药物载体和医用辅助材料[5,6],由于它优良的生物降解性和生物相容性,降解产物无毒,还具有抑制癌细胞的功能,作为缓控释药物载体材料具有极大应用前景[7]。

壳聚糖纳米凝胶药物载体

壳聚糖纳米凝胶药物载体

一壳聚糖简介壳聚糖纳米凝胶粒子近年来在药物释放领域吸引了众多研究者的目光。

因为其将凝胶与纳米粒子的优点结合在一起,具有更强的应用性。

凝胶(Hydrogel)是一种高分子网络体系,性质柔软,能保持一定的形状,具有亲水性及高吸水性,多功能性,生物相容性。

凡是水溶性或亲水性的高分子,通过一定的化学交联或物理交联,都可以形成凝胶。

纳米粒子在药物制剂中具有很多优越性,延长药物在循环中的时间,具有靶向性。

可使大分子顺利通过上皮组织,促进药物的渗透吸收,有效提高药物的生物利用度,减少副作用。

结合以上二者的优点,并且壳聚糖本身除了具备普通高分子材料的物理化学、机械性能稳定以及可接受消毒等相应处理的特性外,还能够在生物体内酶解成易被吸收、无毒副作用的小分子物质,并且不会残留在活体内。

因此壳聚糖制成的纳米凝胶粒子作为药物释放材料具有很好的应用前景。

制备壳聚糖纳米凝胶粒子有很多方法,本文就其制备研究作一综述。

二壳聚糖纳米凝胶粒子的制备1.共价交联的壳聚糖纳米粒子对基于壳聚糖的纳米结构的最早研究主要是对其聚合物链段上的交联的研究。

Watzke与Dieschbourg通过四甲氧基硅烷(tetramethoxysilane,TMOS)与壳聚糖单体上的羟基反应制得了壳聚糖与二氧化硅的纳米复合物。

形成了具有互相贯穿的网络结构的微乳凝胶。

这种纳米复合物一个特别的性质就是:用液态二氧化碳临界点干燥的时候,其网络结构会扩张。

TMOS的引进使之形成非透明的白色固体状物质。

电子扫描电镜显示,经临界点干燥的样品具有大孔结构,一定量时能够散射光。

另外,当反应时液相的pH不一样时,最终得到纳米复合物的结构也不一样。

这一研究虽然形成了聚合物网络结构,却并没有将其与有用的活性药物结合起来。

后来Ohya 等[6 ] 首次报道了采用共价交联法,制备内含5-氟尿嘧啶(5- Fu) 抗癌药物的壳聚糖纳米粒子。

即用戊二醛共价交联壳聚糖分子链上的氨基,制得壳聚糖凝胶纳米球,5-氟尿嘧啶药物固定在纳米球里。

壳聚糖纤维壳聚糖海藻酸钠水凝胶溶胀性能与抑菌性能

壳聚糖纤维壳聚糖海藻酸钠水凝胶溶胀性能与抑菌性能

广东化工2021年第2期· 6 · 第48卷总第436期壳聚糖纤维/壳聚糖/海藻酸钠水凝胶溶胀性能与抑菌性能王浩然,邓言权,李濠镜,姚浩然,邵宗磊,李阳雪,张大伟*(材料科学与工程学院东北林业大学,黑龙江哈尔滨150000)[摘要]制备了壳聚糖(CS)/海藻酸钠(SA)复合水凝胶,并通过加入吸水性壳聚糖长纤维、45 %壳聚糖水刺无纺布、80 %壳聚糖水刺无纺布、100 %壳聚糖水刺无纺布、100 %壳聚糖针刺无纺布这五种纤维,增强复合水凝胶的力学性能,探究了复合水凝胶的吸水溶胀性能与抑菌性能。

结果表明,加入纤维后水凝胶在蒸馏水中的溶胀比明显降低,在碱性环境中,水凝胶的溶胀比显著上升,在偏中性环境中,水凝胶的溶胀比最低;加入纤维后,复合水凝胶仍具有一定的抑菌性,无纤维添加的水凝胶呈现出的抑菌能力一般,而加入了吸水性壳聚糖长纤维的具有最佳的抑菌性能。

[关键词]壳聚糖;海藻酸钠;壳聚糖纤维;水凝胶[中图分类号]TQ [文献标识码]A [文章编号]1007-1865(2021)02-0006-02Preparation and Preperties of Chitosan Fiber/Chitosan/Alginate Hydrogel Wang Haoran, Deng Yanquan, Li Haojing, Yao Haoran, Shao Zonglei, Li Xueyang, Zhang Dawei*(College of Materials Science and Engineering, Northeast Forestry University, Harbin 150000, China) Abstract: Pick to adopt chemical crosslinked chitosan (CS)/sodium alginate (SA) composite hydrogels, and by adding water imbibition of chitosan long fiber, 45 % chitosan spunlace nonwoven spunlace nonwovens, 80 %, 100 % chitosan spunlace nonwoven, 100 % chitosan acupuncture non-woven these five kinds of fiber, enhance the mechanical properties of composite hydrogel, explore the absorbent composite hydrogel swelling properties, mechanical properties, antibacterial properties.The results showed that the swelling ratio of hydrogel in distilled water was significantly decreased after adding fiber. In alkaline environment, the swelling ratio of hydrogel was significantly increased. In neutral environment, the swelling ratio of hydrogel was the lowest.The mechanical properties of the composite hydrogel increased significantly after fiber was added.After the addition of fiber, the composite hydrogel still had some bacteriostasis, and the hydrogel without fiber showed a general bacteriostasis, while the one with the addition of absorbent chitosan long fiber had the best bacteriostasis.Keywords: Chitosan;sodium alginate;chitosan fiber;hydrogel水凝胶作为一种新型的高分子材料,是最具吸引力的软材料之一,具有三维网络结构和可调的物理和化学性质[1]。

海藻酸钠和壳聚糖

海藻酸钠和壳聚糖

海藻酸钠和壳聚糖
海藻酸钠和壳聚糖是两种常见的天然高分子材料,具有广泛的应用前景。

海藻酸钠是一种从海藻中提取的天然多糖,具有很强的水溶性和生物相容性。

它可以用于制备医用敷料、药物缓释系统、食品添加剂等应用领域。

海藻酸钠还具有一定的抗氧化性能和抗菌性能,可以用于保护食品和化妆品等。

壳聚糖是一种从甲壳类动物中提取的天然多糖,具有良好的生物相容性、生物可降解性和生物活性。

它可以用于制备医用敷料、药物缓释系统、骨组织工程等应用领域。

壳聚糖还具有一定的凝胶性能和吸附性能,可以用于废水处理、金属离子吸附等。

海藻酸钠和壳聚糖可以通过交联反应制备出海藻酸钠-壳聚糖复合材料,具有比单一材料更好的性能。

海藻酸钠-壳聚糖复合材料可以用于制备水凝胶、药物控释系统、人工骨等应用领域。

此外,海藻酸钠和壳聚糖还可以与其他材料结合使用,如与金属离子、纳米材料等组装成复合材料,以获得更广泛的应用。

- 1 -。

壳聚糖_海藻酸钠水凝胶的制备及其在药物控释中的应用

壳聚糖_海藻酸钠水凝胶的制备及其在药物控释中的应用

河北科技师范学院学报 第24卷第1期,2010年3月Journa l ofH ebeiNor m alUn i v ersity of Science &Techno logy Vo.l 24No .1M arch 2010壳聚糖/海藻酸钠水凝胶的制备及其在药物控释中的应用郑学芳,刘 纯,廉 琪,贾丹丹,田宏燕,王东军*(河北科技师范学院理化学院,河北秦皇岛,066600)摘要:以戊二醛(GA )为交联剂,壳聚糖作为聚阳离子组分,海藻酸钠作为聚阴离子组分,制备了壳聚糖(CS)海藻酸钠(SA )水凝胶。

探讨了改变溶液的p H 值和交联剂用量等条件对两种水凝胶溶胀性能的影响。

交联剂含量、p H 对CS S A 水凝胶溶胀率的影响较大,且在酸性条件下的水凝胶的溶胀率远大于碱性条件下的溶胀率,包埋在此水凝胶中的牛血清蛋白(BSA )释放随载药介质的p H 值的变化而显著不同,p H 值为1.0条件下载药的水凝胶释药率大于p H 值为7.4,9.18条件下的释药率。

关键词:壳聚糖;海藻酸钠;牛血清蛋白;控制释放中图分类号:O 636.1 文献标志码:A 文章编号:1672 7983(2010)01 0008 04水凝胶对外界刺激如pH 值、溶剂、盐浓度、光等能产生相应的体积变化,广泛应用于药物控制释放、固定化酶、物料萃取、生物材料培养、提纯、蛋白酶的活性控制等领域[2~4]。

壳聚糖(CS)作为一种带正电荷的天然多糖,具有良好的生物相容性和生物降解性[5]。

由于其具有良好的吸水保湿性能[6],作为水凝胶,在药物控制释放上具有良好的发展前途。

海藻酸钠(SA )是一种广泛存在于各类棕色海藻中的天然高分子,可与多价阳离子形成简单的凝胶,成胶条件温和,该类凝胶对机体无毒性,适合作为药物包埋材料。

笔者以戊二醛为交联剂,壳聚糖作为聚阳离子组分,海藻酸钠作为聚阴离子组分制备壳聚糖/海藻酸钠水凝胶(CS SA ),并通过改变溶液的pH 值和交联剂用量等因素来探讨水凝胶的溶胀性能变化。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

International Journal of Biological Macromolecules 50 (2012) 1299–1305Contents lists available at SciVerse ScienceDirectInternational Journal of BiologicalMacromoleculesj o u r n a l h o m e p a g e :w w w.e l s e v i e r.c o m /l o c a t e /i j b i o m acCytotoxicity and biocompatibility evaluation of N,O-carboxymethyl chitosan/oxidized alginate hydrogel for drug delivery applicationXingyi Li a ,Xiangye Kong b ,Zhaoliang Zhang a ,Kaihui Nan a ,LingLi Li a ,XianHou Wang c ,Hao Chen a ,∗aInstitute of Biomedical Engineering,School of Ophthalmology &Optometry and Eye Hospital,Wenzhou Medical College,270Xueyuan Road,Wenzhou 325027,ChinabState Key Laboratory of Biotherapy and Cancer Center,West China Hospital,West China Medical School,Sichuan University,No.1,Keyuan 4th Road,Chengdu 610041,China cDepartment of Lymphoma,Sino-US Center for Lymphoma and Leukemia,Tianjin Medical University Cancer Hospital and Institute,Key Laboratory of Cancer Prevention and Therapy,Tianjin Medical University,Tianjin 300060,Chinaa r t i c l ei n f oArticle history:Received 12February 2012Received in revised form 5March 2012Accepted 12March 2012Available online 20 March 2012Keywords:HydrogelBiocompatibility In vitro In vivoDrug deliverya b s t r a c tIn this paper,covalently cross-linked hydrogel composed of N,O-carboxymethyl chitosan and oxidized alginate was developed intending for drug delivery application.In vitro/vivo cytocompatibility and bio-compatibility of the developed hydrogel were preliminary evaluated.In vitro cytocompatibility test showed that the developed hydrogel exhibited good cytocompatibility against NH3T3cells after 3-day incubation.According to the results of acute toxicity test,there was no obvious cytotoxicity for major organs during the period of 21-day intraperitoneal administration.Meanwhile,the developed hydrogel did not induce any cutaneous reaction within 72h of subcutaneous injection followed by slow degra-dation and adsorption with the time evolution.Moreover,the extraction of developed hydrogel had nearly 0%of hemolysis ratio,which indicated the good hemocompatibility of hydrogel.Based on the above results,it may be concluded that the developed N,O-carboxymethyl chitosan/oxidized alginate hydrogel with non-cytotoxicity and good biocompatibility might suitable for the various drug delivery applications.© 2012 Elsevier B.V. All rights reserved.1.IntroductionIn recent years,numerous implant biomaterials including synthetic and natural materials have been widely used in the biomedical and pharmaceutical field [1–3].Hydrogels are a class of polymers very similar to soft tissue for their high water content,the mechanical properties (low modulus and elasticity),softness,oxy-gen permeability and excellent biocompatibility.According to the resource of materials,hydrogels can be divided into two classes:synthetic materials based hydrogel and natural materials based hydrogel.In the case of synthetic materials based hydrogels,there are presence of some disadvantages including inflammatory reac-tions,material migration as well as the difficulty of removal and so on.Recently,much attention have been oriented to the biocompat-ible,biodegradable hydrogels made from natural polymers that are susceptible to enzymatic degradation [4–6].Chitosan,the second abundant source in nature after cellu-lose,is an aminopolysaccharide obtained by the deacetylation of chitin [7–10].It is composed of N-acetylglucosamine (GlcNAc)and glucosamine (GlcN)residues.There are many parameters∗Corresponding author.Tel.:+8657788833806;fax:+8657788833806.E-mail addresses:dragonhaochen@ ,chehao@ (H.Chen).influencing the properties of chitosan including molecular weight (MW),degree of deacetylation (DD)and etc.[8].Chitosan is water insoluble,but can easily dissolve into some acidic aqueous solu-tion,such as acetic aqueous solution and etc.In order to improve the water solubility of this versatile cationic polysaccharide,several strategies are being made to modify chitosan including PEGtylation,carboxymethylation and etc.realizing its full potential application [7,11].In recent years,an increasing number of in situ gel sys-tems based on chitosan and its derivatives have been viewed in the literature for various pharmaceutical and biomedical applications [6,12].Alginic acid is mostly encountered as a high molecular weight linear copolymer composed of (1–4)-linked ␤-d -mannuronic acid (M units)and ␣-l -guluronic acid (G units)monomers.The neutral-ized form,sodium alginate,as a common thickening agent,has been widely used in the food industry and biomedical field [13].Chi-tosan exists as a cationic polyelectrolyte yet such solution are not compatible with aqueous solutions of sodium alginate,which is an anionic polyelectrolyte.Our previous study has demonstrated that the novel chitosan covalent hydrogel based on N,O-carboxymethyl chitosan and oxidized alginate could be gained by simple mix-ing these two components with an expected weight ratio [14].Although numerous studies have demonstrated that chitosan and alginate were non-cytotoxic,biodegradable,biocompatible suit-able for further various drug delivery applications,its hydrogels0141-8130/$–see front matter © 2012 Elsevier B.V. All rights reserved.doi:10.1016/j.ijbiomac.2012.03.0081300X.Li et al./International Journal of Biological Macromolecules50 (2012) 1299–1305should be carefully checked before its further various drug deliv-ery applications[7,11].In this paper,our studies are focused on the cytotoxicity and biocompatibility evaluation of this novel hydro-gel by means of the in vitro cytocompatibility,acute cytotoxicity, subcutaneous implant test,skin irritation test,and hemolysis test.2.Materials and methods2.1.MaterialsN,O-carboxymethyl chitosan(the degrees of substitution of car-boxymethyl groups on both the amino(N-position)and primary hydroxyl(O-position)sites were approximately85%)and oxidized alginate(the oxidation degree of alginate was about27.8%)were successfully synthesized by our previous study[14].All other chem-icals used in this paper were analytic grade.Distilled water from Milli-Q water system was used to prepare the aqueous solutions.2.2.Preparation of N,O-carboxymethyl chitosan/oxidized alginate auto-gelling systemA calculated weight of oxidized alginate and N,O-carboxymethyl chitosan were dissolved into20ml distilled water to form6%(w/w) and4%(w/w)solutions,respectively.The solutions werefiltered and stored at4◦C overnight for the further usage.Auto gelling solutions were prepared as follows:2ml of N,O-carboxymethyl chi-tosan and oxidized alginate solutions with weight ratio of1:2were mixed at room temperature with gentle stirring to form homoge-neous solution.After that,the auto-gelling solution was placed at 37◦C for30min to form the N,O-carboxymethyl chitosan/oxidized alginate hydrogel.2.3.In vitro cytocompatibility testThe NH3T3cell was used to assess the in vitro cytocompat-ibility of hydrogels.The NH3T3cell was obtained from ACTT (USA)and cultured with DMEM(A)medium at37◦C and5%CO2. N,O-carboxymethyl chitosan and oxidized alginate were ster-ilized by cobalt-ray prior the test.Briefly,N,O-carboxymethyl chitosan/oxidized alginate auto-gelling solution wasfirst prepared by follows:5ml of N,O-carboxymethyl chitosan solution and5ml of oxidized alginate solution was mixed using a vortex mixer at room temperature.Immediately after mixing,the mixture was poured into a24-well cell culture dish at0.6ml or0.2ml for com-pletely or partly covering the bottom of the well,respectively.After incubation at37◦C for30min,the resultant gels adhered to the bottom of wells was rinsed with DMEM medium for three times. NH3T3cells suspended in the DMEM medium were seeded into each well at5.0×105cells/well.After24h,48h and72h incuba-tion,the morphology of cells surrounding gel was observed using an optical microscope(Olympus,Japan).In order to further evalua-tion the cytocompatibility of N,O-carboxymethyl chitosan/oxidized alginate hydrogel,NH3T3cells(5.0×105cell/well)was pre-mixed with N,O-carboxymethyl chitosan solution and then gelled with oxidized alginate solution at37◦C for30min.Subsequently,the cell supporter was incubated with DMEM medium for24h,48h and 72h,respectively.Finally,the morphology of cell inside the hydro-gel was observed with an optical microscope(Olympus,Japan).2.4.Acute toxicity testTen male and10female BALB/c mice,6weeks of age(18–22g), were used to evaluate the acute toxicity of N,O-carboxymethyl chitosan/oxidized alginate hydrogel.All experimental protocols and animal care complied with the Guide for the Care and Use of Laboratory Animals,Institute of Laboratory Animal Resources,Table1Skin irritation test:criteria of classification of the cutaneous reactions.Cutaneous reaction Score Results None0Normal Sporadic or patchy erythema1Irritation Moderate confluent erythema2Irritation Severe erythema and edema3Irritationand were approved by the Institutional Animal Care and Use Committee of Wenzhou Medical College.Twenty mice were ran-domly divided into two groups:a treatment group and a control group,five male andfive female mice for each group.The mice of treatment group were injected with50ml/kg N,O-carboxymethyl chitosan/oxidized alginate auto-gelling solution into the abdomi-nal cavity once,and the mice of control group were injected with 50ml/kg saline solution into the abdominal cavity once.All the animals were observed continuously for21days after the adminis-tration,including the general conditions(the activity,energy,hair, feces,behavior pattern,other clinical signs,etc.),body weight,and mortality.At specific time point(7day,14day and21day),three mice from each group were sacrificed by cervical dislocation,and its major organs including heart,liver,spleen,lung and kidney were removed andfixed in10%formaldehyde solution.Finally,the fixed organs were embedded in paraffin,sectioned and stained with hematoxylin–eosin for the histopathologic examination.2.5.Subcutaneous injection testTwenty four BALB/c mice,6weeks of age(18–22g),were employed for subcutaneous injection of N,O-carboxymethyl chi-tosan/oxidized alginate hydrogel to evaluate the in vivo degradation behavior.Twenty four mice were randomly divided into two groups:a treatment group and a control group,twelve mice for each group.The mice from treatment group were injected with0.5ml N,O-carboxymethyl chitosan/oxidized alginate auto-gelling solu-tion in back subcutaneous tissue and the mice from control group were injected with0.5ml saline solution in back subcutaneous tis-sue.Three mice from each group were sacrificed at1,3,5and7day and the injection site were opened with a surgical scissors for obser-vation the state of hydrogel.Meanwhile,the tissue around with the injected site were carefully removed and subsequentlyfixed in10%buffered formaldehyde,stained with hematoxylin–eosin for further histopathological examination.2.6.Skin irritation testThree healthy New Zealand albino rabbits(2.3–2.5kg),were used to evaluate the skin irritation of N,O-carboxymethyl chitosan/oxidized alginate hydrogel.Briefly,0.5ml of N,O-carboxymethyl chitosan/oxidized alginate auto-gelling solution was directly subcutaneous injected on the left back skin next to backbone and0.5ml of saline solution was directly subcutaneous injected on the right back skin next to backbone for control.The cutaneous reaction surrounding the injection site was evaluated at 24h,48h and72h,using the criteria has been reported in Table1.2.7.Hemolysis testAccording to guide of biological evaluation of medical device(SFDA,China),the hemolysis of N,O-carboxymethyl chi-tosan/oxidized alginate hydrogel was carefully checked.Initially, 2ml of N,O-carboxymethyl chitosan/oxidized alginate auto-gelling solution was placed in an test tube at37◦C for12h to form the hydrogel.Subsequently,20ml of sterile saline was added into test tube with incubation at37◦C for another72h and then the top ofX.Li et al./International Journal of Biological Macromolecules50 (2012) 1299–13051301Fig.1.The morphology of NH3T3cells contact with N,O-carboxymethyl chitosan/oxidized alginate hydrogel as function with time. leaching solution was collected andfiltered with0.22␮m mem-brane for further usage.A8ml blood samples was freshly collected from three femalenormal rabbits into an anticoagulin tube and gently mixed.Thepooled blood was diluted with10ml saline solution for the furtherusage.The hemolysis test was performed by method as the follow-ing:Briefly,10ml of hydrogel extraction,distilled water and salinesolution were respectively poured into50ml test tube and placedat37◦C equilibrium for30min.After that,0.2ml of diluted bloodwas added to each test tube with gent shake and the resultant solu-tion was placed at37◦C incubation for another60min.Finally,theabsorbance of samples was recorded with a UV-visible spectrome-ter(UV-8000,Shanghai Metash Instrument Co.Ltd.)at545nm,andthe hemolysis ratio was calculated by the following formula:Hemolysis ratio(%)=A hydrogel extraction−A saline solutionA distilled water−A saline solution×100%3.Results and discussion3.1.Gel formation and in vitro cytocompatibility testThe novel covalently cross-linked chitosan based hydrogel was formed by simple mixing N,O-carboxymethyl chitosan solution with oxidized alginate solution at room temperature.Because of the coexistence of amino,hydroxyl,and carboxymethyl groups associated with N,O-carboxymethyl chitosan chain,the plentiful aldehyde and hydroxyl groups along the oxidized alginate chain, the Schiff base as well as hydrogen bond formation were expected after blending N,O-carboxymethyl chitosan and oxidized alginate solutions,yet resulting in the sol–gel transition of system as a function with time.And the more detailed description on the for-mation of N,O-carboxymethyl chitosan/oxidized alginate hydrogel has been presented in our previous study[14].Although numerous studies have demonstrated that the chitosan as well as alginate were non-cytotoxic,biodegradable and biocompatible polymer,its derivates should be carefully checked before its further application. The preliminary study on the in vitro cytotoxicity has been demon-strated that the developed hydrogel was non-cytotoxic against NH3T3cells[14].Herein,the further study on the cytocompati-bility of hydrogel was performed by observing the morphology of NH3T3cells surrounding or inside the hydrogel as a function with time.As depicted in Fig.1,it clearly observed that the NH3T3cells surrounding the gels adhered to,spread and grew on the cell cul-ture dish with the same morphology as those on normal cell culture dishes after24h,48h and72h of seeding,indicating that the devel-oped hydrogel was non-cytotoxic against surrounding NH3T3cells. However,for the cell of seeding on the completely covered hydro-gel,no cells were observed to spread and grew on the hydrogel and the major of cells were foundfloating and formed cell cluster after1302X.Li et al./International Journal of Biological Macromolecules 50 (2012) 1299–1305Fig.2.Hematoxylin and eosin staining of major organs (cardiac muscle,liver,spleen,lung and kidneys)after intraperitoneal administration of 50ml/kg N,O-carboxymethyl chitosan/oxidized alginate hydrogel.24h,48h and 72h of seeding,indicating that the surface of hydrogel was disadvantage for the cell adhesion and proliferation.However,the result of a lower adhesion of cells on the surface of chitosan derivative based hydrogel was not specific for N,O-carboxymethyl chitosan/oxidized hydrogels.It has been found to be difficult for cells to adhere to and grow on other chitosan and chitosan derivates based hydrogels [15,16].This might be explained by the excessive hydrophilicity of hydrogel surface was disadvantage for the cell adhesion and proliferation [17,18].Except that,the NH3T3cells were also encapsulated into the hydrogel during the hydrogel for-mation for evaluation the cell adhesion and proliferation in DMEM medium without differentiation factors up to 3days.According to Fig.1,it revealed that NH3T3cells with normal morphology were well spread and grew inside the hydrogel,further support-ing that the developed hydrogel with excellent cytocompatibility had the potential application in cell/scaffold.Therefore,we specu-lated that the covalent cross-linking between N,O-carboxymethyl chitosan and oxidized alginate did not compromise cell viability.Meanwhile,the porous structure of hydrogel provided a pathway that sufficient nutrients and oxygen from the medium could be delivered to the cells inside the hydrogel,yet supporting the cell growth and proliferation,which is in accordance with previousreport [1].Based on the above studies,it might be concluded that the developed hydrogel with a better cytocompatibility as com-pared to other injectable hydrogel systems based on methacrylated chitosan might have great potential application in the drug delivery and tissue engineering [19].3.2.Acute toxicity testAccording to the previous study,the acute toxicity test was per-formed by observing the state of rats as a function with time.No death of all rats was occurred during the whole 21-day periodical study,and no toxic response was found in mice.The rats exhib-ited normal energy,normal behavior,free movement,and shining hair.The mice were sensitive to sound,light,and other stimula-tions.There was no flare and no ulceration in the skin.They had no salivation or vomit,no mouth or nose dryness or edema,no running nose or eye secretion.The body weight of rats from N,O-carboxymethyl chitosan/oxidized alginate hydrogel group showed no significance difference compared with that from the saline solu-tion control group (data not shown).Furthermore,the major organs of rats from each group at specific time point was stained with hematoxylin–eosin for histopathologic examination,as presentedX.Li et al./International Journal of Biological Macromolecules50 (2012) 1299–13051303Fig.3.In vivo gel-formation and remove process of N,O-carboxymethyl chitosan/oxidized alginate hydrogel as function with time.in Fig.2.From Fig.2,we could clearly observe that cardiac myocytes from hydrogel groups are clear and arranging in good order,and no hemorrhage,necrosis,or inflammatory exudate was observed at7, 14and21days after administration.For the liver from hydrogel groups,no hepatocellar degeneration or necrosis,and no neu-trophil,lymphocyte,and macrophage infiltration was observed not matter at7days or21days.The normal microstructure of spleen, lung and kidneys tissue from hydrogel groups were also observed no matter at7days or14and21days.All these results suggested that the developed N,O-carboxymethyl chitosan/oxidized alginate hydrogel was non-toxic for the major organs after21days admin-istration suitable for the further various drug delivery application.3.3.Subcutaneous implant testIn order to investigate the in vivo destiny as well as biodegrad-ability of the developed N,O-carboxymethyl chitosan/oxidized alginate hydrogel,we observed the remove process of hydrogel in situ after S.C.injection as a function with time,as presented in Fig.3.According to Fig.3,it clearly observed that the trans-parent hydrogel was formed in situ after2h of S.C.injection, indicating that the quick gelation could take place as placing in physiological temperature and pH condition.Five days later,the transparent hydrogel became opaque gradually combined with the volume decrease as the time proceeding,indicating the degrada-tion or adsorption of hydrogel might be occurred.Seven days later, the beige hydrogel in situ was still observed suggesting the slow degradation or adsorption of hydrogel.The histopathologic exam-ination was also employed to evaluate microscopic changes of the tissue surrounding the inject site.As shown in Fig.4,it clearly observed that there is numerous neutrophil infiltration in the hydrogel at day1after injection,indicating that the degradation or adsorption of hydrogel was occurred.As well known to us, chitosan monomer can induce the migration of polymorphonu-clear leukocytes and macrophages in the applied tissue at the early stage[20,21].Because of the plenty of aminoglucose unite of N,O-carboxymethyl chitosan in the hydrogel,the numerous neutrophil infiltration in the hydrogel might be induced by the N,O-carboxymethyl chitosan component in the hydrogel,which is in accordance with the report of Matsunaga et al.[20].With the time proceeding,the neutrophil infiltration in the hydrogel was gradually decreased.Seven days later,no neutrophil cells were observed in tissue at injection.However,there was a newfibrous capsule surrounding hydrogels,indicating that N,O-carboxymethyl chitosan/oxidized alginate hydrogel could be slowly degraded or adsorbed by neutrophil cells after S.C.injection.3.4.Skin irritation testBefore humans can be exposed to such substances,the tendency of new chemicals to cause skin irritation must be carefully checked. Assessment of skin irritation potential is an important part of any comprehensive toxicology programme for new chemicals and con-sumer products.Even today,thefinal preclinical safety assessment of chemicals is largely based on animal experiments[22].In this paper,the New Zealand albino rabbit was employed to evaluate the skin irritation of N,O-carboxymethyl chitosan/oxidized alginate hydrogel,and the result were summarized in Table2.According to Table2,we couldfind that the S.C.injection of hydrogel on the rabbit back skin did not induce any cutaneous reaction compared with that of S.C.injection of saline solution(negative control)in all the rabbit at24,48and72h of administration.This means that the developed hydrogel was a non skin irritation system,yet could be served as drug carrier for the transdermal/local drug delivery system without any skin irritation.3.5.Hemolysis testGenerally,in vitro erythorocyte-induced hemolysis is con-sidered to be a simple and reliable measure for estimating1304X.Li et al./International Journal of Biological Macromolecules 50 (2012) 1299–1305Fig.4.Hematoxylin and eosin stained sections tissue samples from injection site after N,O-carboxymethyl chitosan/oxidized alginate hydrogel subcutaneous injection (400×).blood compatibility of materials [23].The behavior of chitosan formulations in vivo can be predicted by investigating the degree of hemolysis [23,24].Previous study suggested that the blood com-patibility of chitosan and its derivates could be evaluated in terms of hemolysis [25].Notara et al.[26]has investigated the hemocom-patibility of chitosan-alginate physical gel and the result showed that chitosan-alginate physical gel has excellent hemocompati-bility suitable for further drug delivery application.Herein,the hemocompatibility of N,O-carboxymethyl chitosan/oxidized algi-nate hydrogel was preliminary evaluated by a simple colorimetry.As presented in Fig.5,the blood sample incubation with hydro-gel extraction solution showed no evidence of hemolysis,while the obvious hemolysis was observed in distilled water group.More specifically,as presented in Table 3,we could find that the sample from the N,O-carboxymethyl chitosan/oxidized alginate hydrogel group had about 0.97%of hemolysis ratio,which was far smaller than 5%international standard,indicating that the N,O-carboxymethyl chitosan/oxidized alginate hydrogel has excellent hemocompatibility suitable for various drug delivery applications.Table 2Cutaneous reactions in rabbit after administration of 0.5ml N,O-carbomethyl chi-tosan/oxidized alginate hydrogel as a function with time.Treatment and rabbit (3)Time (h)2448720.5ml saline solution 1(right)0002(right)0003(right)0.5ml N,O-carboxymethyl chitosan/oxidized alginate hydrogel 1(left)0002(left)0003(left)Fig.5.Hemolysis test on (a)distilled water,(b)saline solution and (c)hydrogel extractions.Table 3Results of the hemolysis test for N,O-carboxymethyl chitosan/oxidized alginate hydrogel extraction solutions.GroupsSamplesTotal of hemolysis ratio (%)123Distilled water 0.52570.55720.5456Saline solution0.12650.12260.12050.93±0.73Hydrogel extraction 0.13360.12460.1247Hemolysis ratio (%)1.780.460.55X.Li et al./International Journal of Biological Macromolecules50 (2012) 1299–130513054.ConclusionIn this paper,in vitro and in vivo compatibility of N,O-carboxymethyl chitosan/oxidized alginate hydrogel was carefully evaluated by means of in vitro cytocompatibility,acute cytotoxic-ity,subcutaneous injection test,skin irritation test,and hemolysis test before its further various drug delivery applications.In vitro cytocompatibility test revealed that the developed hydrogel was non-cytotoxic and well cytocompatibility against NH3T3cells after 3days of seeding.Acute cytotoxicity test suggested that the devel-oped hydrogel was non-toxicity for major organs suitable for the various drug delivery applications,while subcutaneous injection test revealed that the N,O-carboxymethyl chitosan/oxidized algi-nate hydrogel could slowly degraded or adsorbed after S.C.injection with time evolution.On the other hand,N,O-carboxymethyl chi-tosan/oxidized alginate hydrogel did not induce any cutaneous reaction after72h of the subcutaneous injection in rabbit model and did not cause any hemolysis after co-incubation with the blood solution.All these results strongly suggested that the developed N,O-carboxymethyl chitosan/oxidized alginate hydrogel was a safe, non-toxic carrier with well in vitro and in vivo compatibility suitable for the various drug delivery applications.AcknowledgementThis work was supported by Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents.References[1]R.Jin,L.S.Moreira Teixeira,P.J.Dijkstra,M.Karperien,C.A.Van Blitterswijk,Z.Y.Zhong,J.Feijen,Biomaterials30(2009)2544–2551.[2]H.Zitter,H.Plenk Jr.,J.Biomed.Mater.Res.21(1987)881–896.[3]S.Ozawa,S.Kasugai,Biomaterials17(1996)23–29.[4]N.Bhattarai,J.Gunn,M.Zhang,Adv.Drug Deliv.Rev.62(2010)83–99.[5]B.O.Haglund,R.Joshi,K.J.Himmelstein,J.Control.Release41(1996)229–235.[6]E.Ruel-Gariepy,J.C.Leroux,Eur.J.Pharm.Biopharm.58(2004)409–426.[7]R.Jayakumar,M.Prabaharan,R.L.Reis,J.F.Mano,Carbohydr.Polym.62(2005)142–158.[8]E.Khor,L.Y.Lim,Biomaterials24(2003)2339–2349.[9]X.Y.Li,X.Y.Kong,S.Shi,X.H.Wang,G.Guo,F.Luo,X.Zhao,Y.Q.Wei,Z.Y.Qian,Carbohydr.Polym.82(2010)904–912.[10]R.A.A.Muzzarelli,Carbohydr.Polym.76(2009)167–182.[11]R.A.A.Muzzarelli,F.Tanfani,M.Emanuelli,S.Mariotti,Carbohydr.Res.107(1982)199–214.[12]S.Lü,M.Liu,B.Ni,Chem.Eng.J.160(2010)779–787.[13]J.A.Rowley,G.Madlambayan,D.J.Mooney,Biomaterials20(1999)45–53.[14]X.Y.Li,Y.H.Weng,X.Y.Kong,Z.L.Zhang,X.H.Wang,H.Chen,A covalently cross-linked polysaccharide hydrogel for potential applications in drug delivery and tissue engineering.J.Mater Sci:Mater Med under review.[15]S.Sakai,Y.Yamada,T.Zenke,K.Kawakami,J.Mater.Chem.19(2009)230–235.[16]K.Ono,Y.Saito,H.Yura,K.Ishikawa,A.Kurita,T.Akaike,M.Ishihara,J.Biomed.Mater.Res.49(2000)289–295.[17]C.R.Nuttelman,D.J.Mortisen,S.M.Henry,K.S.Anseth,J.Biomed.Mater.Res.A57(2001)217–223.[18]M.M.Stevens,J.H.George,Science310(2005)1135–1138.[19]Y.Hong,H.Song,Y.Gong,Z.Mao,C.Gao,J.Shen,Acta Biomater.3(2007)23–31.[20]T.Matsunaga,K.Yanagiguchi,S.Yamada,N.Ohara,T.Ikeda,Y.Hayashi,J.Biomed.Mater.Res.A76(2006)711–720.[21]P.J.VandeVord,H.W.Matthew,S.P.DeSilva,L.Mayton,B.Wu,P.H.Wooley,Mater.Res.59(2002)585–590.[22]M.P.Vinardell,M.Mitjans,J.Pharm.Sci.97(2008)46–59.[23]C.M.Deng,L.Z.He,M.Zhao,D.Yang,Y.Liu,Carbohydr.Polym.69(2007)583–589.[24]D.W.Lee,K.Powers,R.Baney,Carbohydr.Polym.58(2004)371–377.[25]Y.Yang,Y.Zhou,H.Chuo,S.Wang,J.Yu,J.Appl.Polym.Sci.106(2007)372–377.[26]M.Notara,C.A.Scotchford,D.M.Grant,N.Weston,G.A.F.Roberts,J.Biomed.Mater.Res.A89(2009)854–864.。

相关文档
最新文档